Yesterday, a much-anticipated announcement was made on a variety of media outlets – European regulators approved Mosquirix, the first-ever malaria vaccine. Although this is an important first step, it is not the final blow to a disease that infects hundreds of millions and claims around 700,000 lives annually, most of them children under five years. The reported effectiveness of the vaccine appears to be less than 50% and it is unclear how, when or even whether it will be dep
In it's July 3-9 edition, the Pacific Cost Business Times reported on the pre-clinical study that we just completed on our malaria product, Artelutrine, a combination of active ingredients Artemisinin and Lumefantrine.
We just released our new video on our contribution to solving the malaria problem. Our gratitude goes to Dariush Apfelthaler (vide0) as well as David "Blaze" Sepowski and David Decker (music). The video is available on YouTube.